Northern Trust’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $753K | Sell |
|
|||||
|
2022
Q3 | $866K | Buy |
|
|||||
|
2022
Q2 | $410K | Sell |
|
|||||
|
2022
Q1 | $334K | Sell |
|
|||||
|
2021
Q4 | $317K | Sell |
|
|||||
|
2021
Q3 | $344K | Sell |
|
|||||
|
2021
Q2 | $473K | Sell |
|
|||||
|
2021
Q1 | $1.68M | Sell |
|
|||||
|
2020
Q4 | $4.99M | Sell |
|
|||||
|
2020
Q3 | $3.99M | Sell |
|
|||||
|
2020
Q2 | $4.11M | Buy |
|
|||||
|
2020
Q1 | $2.96M | Buy |
|
|||||
|
2019
Q4 | $2.61M | Sell |
|
|||||
|
2019
Q3 | $1.78M | Buy |
|
|||||
|
2019
Q2 | $3.55M | Buy |
|
|||||
|
2019
Q1 | $3.51M | Buy |
|
|||||
|
2018
Q4 | $3.65M | Sell |
|
|||||
|
2018
Q3 | $7.1M | Sell |
|
|||||
|
2018
Q2 | $11.3M | Buy |
|
|||||
|
2018
Q1 | $14.6M | Buy |
|
|||||
|
2017
Q4 | $11.3M | Buy |
|
|||||
|
2017
Q3 | $3.44M | Sell |
|
|||||
|
2017
Q2 | $3.4M | Buy |
|
|||||
|
2017
Q1 | $3.74M | Buy |
|
|||||
|
2016
Q4 | $2.25M | Buy |
|
|||||
|
2016
Q3 | $2.13M | Buy |
|
|||||
|
2016
Q2 | $2.36M | Sell |
|
|||||
|
2016
Q1 | $3.25M | Buy |
|
|||||
|
2015
Q4 | $3.54M | Buy |
|
|||||
|
2015
Q3 | $3.35M | Buy |
|
|||||
|
2015
Q2 | $731K | Buy |
|
|||||
|
2015
Q1 | $295K | Buy |
|
|||||
|
2014
Q4 | $158K | Hold |
|
|||||
|
2014
Q3 | $150K | Sell |
|
|||||
|
2014
Q2 | $648K | Buy |
|
|||||
|
2014
Q1 | $355K | Buy |
|